Cenobamate Shows Promise for Kids With Hard-to-Treat Epilepsy

Source: Pediatric neurology

Summary

This study looked at the safety and effectiveness of a medication called cenobamate in children and teenagers under 18 years old who have epilepsy that does not respond well to other treatments. The researchers focused on how well cenobamate could reduce the number of seizures in these young patients. A total of 31 patients participated in the study, and the researchers also monitored any side effects from the medication.

The findings showed that cenobamate was effective for many of the participants. About 52% of the patients experienced a significant reduction in their seizures, with some seeing a decrease of 75% to 100%. On average, patients had an 80% reduction in seizure frequency. However, some patients did not see any improvement or even had an increase in seizures. The most common side effect reported was sedation, which means feeling very sleepy, and some patients also experienced mood changes.

This research is important because it suggests that cenobamate can help children and teenagers with difficult-to-treat epilepsy by reducing the number of seizures they have. It also indicates that cenobamate might allow patients to use fewer medications overall. However, the study had a small number of participants, and more research is needed to confirm these results and understand the long-term effects of cenobamate in young patients.

Original source